Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity	Abnormalities, Multiple, Alstrom syndrome, Bardet-Biedl syndrome, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Hyperphagia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, brain disorder, central nervous system disorder, central nervous system malformation, eye disorder, hereditary disease, hereditary motor and sensory neuropathy, hypothalamic disorder, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, retinitis pigmentosa	Recruiting	Phase 4	2026-06-29		NCT07674290

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Rhythm Pharmaceuticals, Inc.	7
Tom Hühne	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospital Essen, Deparment of Pediatrics II	Essen	Germany	1